Treatment with the β2-AR selective agonist salbutamol significantly ameliorated the severity of arthritis and abnormal histopathology of joints and inhibit thymus lymphocyte and FLS proliferation from AA rats in vivo. These effects may be mediated by inhibition of DC maturation and promotion of tolerance. This evidence concerns the gene ADRB2 and arthritic joint disease.